GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neutra Corp (OTCPK:NTRR) » Definitions » Return-on-Tangible-Equity

Neutra (Neutra) Return-on-Tangible-Equity : 0.00% (As of Oct. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Neutra Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Neutra's annualized net income for the quarter that ended in Oct. 2023 was $-0.22 Mil. Neutra's average shareholder tangible equity for the quarter that ended in Oct. 2023 was $-0.91 Mil. Therefore, Neutra's annualized Return-on-Tangible-Equity for the quarter that ended in Oct. 2023 was N/A%.

The historical rank and industry rank for Neutra's Return-on-Tangible-Equity or its related term are showing as below:

NTRR's Return-on-Tangible-Equity is not ranked *
in the Biotechnology industry.
Industry Median: -46.42
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Neutra Return-on-Tangible-Equity Historical Data

The historical data trend for Neutra's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra Return-on-Tangible-Equity Chart

Neutra Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neutra Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Neutra's Return-on-Tangible-Equity

For the Biotechnology subindustry, Neutra's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neutra's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neutra's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Neutra's Return-on-Tangible-Equity falls into.



Neutra Return-on-Tangible-Equity Calculation

Neutra's annualized Return-on-Tangible-Equity for the fiscal year that ended in Jan. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Jan. 2023 )  (A: Jan. 2022 )(A: Jan. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Jan. 2023 )  (A: Jan. 2022 )(A: Jan. 2023 )
=-0.561/( (-1.023+-0.739 )/ 2 )
=-0.561/-0.881
=N/A %

Neutra's annualized Return-on-Tangible-Equity for the quarter that ended in Oct. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Oct. 2023 )  (Q: Jul. 2023 )(Q: Oct. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Oct. 2023 )  (Q: Jul. 2023 )(Q: Oct. 2023 )
=-0.22/( (-0.881+-0.936)/ 2 )
=-0.22/-0.9085
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Oct. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Neutra  (OTCPK:NTRR) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Neutra Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Neutra's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra (Neutra) Business Description

Traded in Other Exchanges
N/A
Address
54 Sugar Creek Center Boulevard, Suite 200, Sugar Land, TX, USA, 77478
Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243